What Happened?
Los Angeles, CA-based Enochian-BioSciences Appointed Mark Dybul as Chief Executive Officer and Director
About the Company
Enochian BioSciences (formerly DanDrit Biotech USA Inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for HIV/AIDS and cancer.
About the Person
Mark Dybul is Chief Executive Officer and Director at Enochian BioSciences. Previously, Mark held various senior HR leadership roles in the industry.
Info Source
News
Short Profile